Products

Anti-DLL4 × Anti-VEGF Bispecific Antibody (Bi-sdAb, A1) (NANO-MZ001)

This bispecific binding molecule is useful as pharmacologically active agents in compositions in the prevention, treatment, alleviation and diagnosis of diseases or conditions that can be modulated by inhibition of DII4, such as cancer. It is also capable of blocking DLL4 and VEGF activation as well as inhibiting the VEGF induced Erk phosphoryaltion.      

Specifications
Targets
DLL4 & VEGF
Type
Bi-sdAb
Expression Host
CHO
Species Reactivity
Human
Target 1
DLL4 (Delta like ligand 4)
Host
Llama
Clone
DLLBII018
Target 2
VEGF
Host
Llama
Clone
VEGFBII038
Purity
>95% judged by SDS-PAGE under reducing condition
Applications
ELISA
Related Disease
Human colon cancer
Targets
Target 1
DLL4 (Delta like ligand 4)
Gene ID
54567
UniProt ID
Q9NR61
Alternative Names
DLL4; delta-like 4 (Drosophila); hdelta2; delta-like protein 4; delta4; delta 4; delta ligand 4; notch ligand DLL4
Target 2
VEGF
Alternative Names
VEGF; Vascular endothelial growth factor

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email:

45-1 Ramsey Road, Shirley, NY 11967, USA     Tel: 1-631-871-5806    Fax: 1-631-207-8356    Email:
Terms of Service-Privacy Policy     © 2007 - 2017 Creative-Biolabs All Rights Reserved